MyFinsight
Home
Blog
About
Contact
Back
Cash Flow
CNS Pharmaceuticals, Inc. (CNSP)
CNS Pharmaceuticals, Inc. (CNSP)
source: myfinsight.com
Proceeds from equity
issuance
$500,878
Net cash provided by
financing activities
$404,660
Canceled cashflow
$96,218
Net change in cash
and cash...
-$4,250,137
Canceled cashflow
$404,660
Accounts payable and
accrued expenses
$577,795
Stock-based compensation
$2,555
Depreciation
$1,868
Payments on notes payable
$96,218
Net cash used in
operating activities
-$4,648,618
Canceled cashflow
$582,218
Net cash used in
investing activities
-$6,179
Net loss
-$4,937,046
Prepaid expenses and
other current assets
$293,790
Purchase of property and
equipment
$6,179
Back